79 results
S-3ASR
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
for future issuance as of March 31, 2024 under our 2019 Stock Option and Incentive Plan;
S-5
1,997,027 shares of common stock reserved … Stock Option and Incentive Plan;
1,997,027 shares of common stock reserved for the future issuance as of March 31, 2024 under our 2019 Employee Stock
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
incentive compensation determined based upon the achievement of financial, operational and individual performance metrics as well as through equity … in “Primary Elements of Our Executive Compensation Program—2023 Base Salary” below.
Annual Short-Term Incentive Compensation. As described in more detail below
8-K
EX-1.1
AKRO
Akero Therapeutics Inc
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
in, and the grant of options and awards under existing equity incentive plans described in, the Registration Statement, the Pricing Disclosure Package … as an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”) so qualifies, (ii) each grant of a Stock Option
424B5
n5kqsteq8 tiqgx
6 Mar 24
Prospectus supplement for primary offering
5:16pm
424B5
i170rl0fo37cdx
4 Mar 24
Prospectus supplement for primary offering
5:21pm
S-8
EX-5.1
tbkguf7ndpi h5td
29 Feb 24
Registration of securities for employees
4:42pm
S-8
iscwelts5w8h4wj
29 Feb 24
Registration of securities for employees
4:42pm
S-8
2sgrvfzkk7z7ujjvx7v
29 Feb 24
Registration of securities for employees
4:42pm
8-K
EX-1.1
a24x36ej 0lt
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm
424B5
7t4iocg64cprlc8 f566
17 May 23
Prospectus supplement for primary offering
4:45pm
8-K
EX-1.1
lg5s96r9n12muj
16 Sep 22
Entry into a Material Definitive Agreement
4:02pm